Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Attenuated familial adenomatous polyposis × Endoscopy, Gastrointestinal × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Adenomatous Polyposis Coli 2 Rectal Neoplasms 1 Duodenal Neoplasms 1 Attenuated familial adenomatous polyposis 1

Interventions

obeticholic acid 1 Specimen Handling 1 Erlotinib Hydrochloride 1 Endoscopy, Gastrointestinal 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05223036 2026-03-18

Testing Obeticholic Acid for Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Suspended

Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡